Cormorant Asset Management, LP - Oct 4, 2024 Form 3 Insider Report for OnKure Therapeutics, Inc. (OKUR)

Role
10%+ Owner
Signature
CORMORANT ASSET MANAGEMENT, LP By: /s/ Bihua Chen, Managing Member
Stock symbol
OKUR
Transactions as of
Oct 4, 2024
Transactions value $
$0
Form type
3
Date filed
10/15/2024, 04:08 PM
Previous filing
Oct 1, 2024
Next filing
Oct 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OKUR Class A Common Stock 1.84M Oct 4, 2024 See Footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Cormorant Asset Management, LP serves as the investment manager to Cormorant Global Healthcare Master Fund, LP (the "Master Fund"), Cormorant Private Healthcare Fund III, LP ("Fund III"), Cormorant Private Healthcare Fund IV, LP ("Fund IV"), Cormorant Private Healthcare Fund V, LP ("Fund V") and a managed account (the "Account"). Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC serve as the general partners of the Master Fund, Fund III, Fund IV and Fund V, respectively. Bihua Chen serves as the managing member of Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare GP IV, LLC and Cormorant Private Healthcare GP V, LLC, and the general partner of Cormorant Asset Management, LP.
F2 Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary interest therein, and the filing of this Form 3 shall not be construed as an admission that any of the Reporting Persons is the beneficial owner of any such shares for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.
F3 Represents (i) 434,934 shares of Class A Common Stock beneficially owned by the Master Fund, (ii) 1,109,451 shares of Class A Common Stock beneficially owned by Fund III, (iii) 235,480 shares of Class A Common Stock beneficially owned by Fund IV, (iv) 49,929 shares of Class A Common Stock beneficially owned by Fund V, and (v) 7,945 shares of Class A Common Stock beneficially owned by the Account.